InsiderTrades

Form 4 for BDSX BIODESIX INC

Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-10 · accession 0000905148-25-003932 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-11-13 2025-11-10 BDSX Pestano Gary Anthony Chief Development Off S - Sale+OE $7.62 -23 7,939 -0.3% -$175.26
D 2025-11-13 2025-11-10 BDSX Pestano Gary Anthony Chief Development Off M - OptEx — +69 7,962 +0.9% —
D 2025-11-13 2025-11-10 BDSX Pestano Gary Anthony Chief Development Off M - OptEx $0.00 -69 68 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-10 S D 23 $7.62 7,939 D — —
2 Common Common Stock 2025-11-10 M A 69 — 7,962 D — — (F1) These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025. (F2) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
3 Derivative Restricted Stock Units 2025-11-10 M D 69 $0.00 68 D — · — to — 69 Common Stock (F1) These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025. (F2) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F4) These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.